Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypoxia Imaging in Soft Tissue Sarcoma Using 18F-FAZA PET/MRI
NCT03418818Active, not recruiting
- Sponsor
- University Health Network
- Start
- Mar 2018
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Fluoroazomycin arabinoside F-18 in sarcoma (2 arms), sponsored by University Health Network. Primary endpoint: Grade of FAZA uptake in the primary tumor at 2 years. Started Mar 2018; status: active, not recruiting.
02
Drugs
Fluoroazomycin arabinoside F-18
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT03418818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418818.